Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 175   

Articles published

GSK 1,423.97 -19.53 (-1.35%)
price chart
5 Stunning Reasons Why GlaxoSmithKline plc And AstraZeneca plc Could ...
While investors in AstraZeneca (LSE: AZN) have experienced a very strong 2014 thus far, with shares in the pharmaceutical major gaining 27%, it's been a very different story for their counterparts in GlaxoSmithKline (LSE: GSK). Indeed, the latter has ...
Why GlaxoSmithKline plc Has Further To Fall
Investors in pharmaceutical giant GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have taken a beating lately. At 1450p, the stock is 15% off its 52-week high of 1706p.
China's decision to impose a record fine on GlaxoSmithKline Plc...  Mynextfone
The Morning Risk Report: China Glaxo Conviction Raises Bribery Stakes  Wall Street Journal (blog)
Related articles »  
Turn �10k Into �18.5k With GlaxoSmithKline plc
The FTSE 100's other big pharmaceuticals company, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) hasn't been doing quite so well - for one thing, it hasn't had its shares boosted by takeover fever.
How Will GlaxoSmithKline (GSK) Stock Be Affected by This Lawsuit?
GlaxoSmithKline plc Stock Rating Reaffirmed by Killik (GSK)  Intercooler
Related articles »  
Are Barclays PLC, GlaxoSmithKline plc & Tesco PLC Classic Contrarian Buys?
Barclays (LSE: BARC), GlaxoSmithKline (LSE: GSK) and Tesco (LSE: TSCO) are some of the most renowned companies on the FTSE 100, and the most troubled.
Related articles »  
Is It Time to Buy GlaxoSmithKline plc Stock?
The U.K. pharma giant GlaxoSmithKline (NYSE: GSK ) is one such company that has struggled to overcome the loss of exclusivity for top-selling drugs like Advair.
3 Reasons Why GlaxoSmithKline plc Is The Buy Of 2014!
After a stunning 2013, many UK investors have been surprised at the 1% gains made by the FTSE 100 so far in 2014. However, even that compares very favourably to the performance of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) year-to-date, with the ...
Will GlaxoSmithKline plc's Vaccine Stop Ebola?
GlaxoSmithKline plc (LSE: GSK) is leading the race to try and find a vaccine that will stop the advance of the deadly Ebola virus, which is currently spreading across West Africa.
GlaxoSmithKline plc (ADR) (NYSE:GSK) and NIH Spearheading Development of ...  BasicsMedia
Ebola Vaccine: First-Ever Human Trials For Experimental Drug To Begin Soon  International Business Times
Related articles »  
Is GlaxoSmithKline plc's Opportunity AstraZeneca plc's Threat?
There are no two better examples of this fact than the case of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and AstraZeneca (LSE: AZN) (NYSE: AZN.
3 Reasons Why GlaxoSmithKline plc Could Shoot The Lights Out
Life as a GlaxoSmithKline (LSE: GSK) shareholder has been rather uncomfortable during 2014. That's because the company continues to be embroiled in bribery allegations that are causing sentiment to weaken and, as a result, its shares are taking a ...
Related articles »  
GlaxoSmithKline Plc share price up, receives a $489-million fine for China bribery
GlaxoSmithKline Plc was imposed a fine of �297 million ($489 million) and a top executive received a suspended sentence, for bribing doctors in China, ending a 15-month investigation.
GlaxoSmithKline (GSK) Fined $488.8 Million for 'Massive Bribery Network ...  ABC News
China fines drugmaker GSK record US$489m  The Star Online
Related articles »